Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Brachytherapy

• Publication date

  2016-07-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.brachy.2016.03.014PMID 27317949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rectal dose constraints for salvage iodine-125 prostate brachytherapy.

  2016cited by this paper
• Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.

  2015cited by this paper
• Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.

  2015cited by this paper
• Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.

  2014cited by this paper
• Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: a retrospective study regarding toxicity, biochemical outcome and quality of life.

  2014cited by this paper
• Salvage partial brachytherapy for prostate cancer recurrence after primary brachytherapy

  2014cited by this paper
• In regard to Miralbell et al. Re: Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy.

  2013cited by this paper
• Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer.

  2013cited by this paper
• Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy.

  2012cited by this paper
• Estimation of α/β for late rectal toxicity based on RTOG 94-06.

  2011cited by this paper
• Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.

  2011cited by this paper
• Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy.

  2010cited by this paper
• Salvage permanent perineal radioactive‐seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy

  2009cited by this paper
• Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer.

  2009cited by this paper
• Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate‐specific antigen failure

  2007cited by this paper
• Magnetic resonance image‐guided salvage brachytherapy after radiation in select men who initially presented with favorable‐risk prostate cancer

  2007cited by this paper
• Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.

  2007cited by this paper
• Management of prostate cancer recurrences after radiation therapy‐brachytherapy as a salvage option

  2007cited by this paper
• GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer.

  2005cited by this paper
• Halftime for repair of sublethal damage in normal bladder and rectum: an analysis of clinical data from cervix brachytherapy

  2005cited by this paper
• Prostate cancer radiotherapy dose response: an update of the fox chase experience.

  2004cited by this paper
• Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio

  2003cited by this paper
• Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio.

  2003cited by this paper
• Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases.

  2002cited by this paper
• Is α/β for prostate tumors really low?

  2001cited by this paper
• Is alpha/beta for prostate tumors really low?

  2001cited by this paper
• Palladium-103 brachytherapy for prostate carcinoma.

  2000cited by this paper
• Permanent brachytherapy as salvage treatment for recurrent prostate cancer.

  1999cited by this paper
• Salvage brachytherapy for localized prostate cancer after radiotherapy failure.

  1999cited by this paper
• Fractionation and protraction for radiotherapy of prostate carcinoma.

  1999cited by this paper
• American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.

  1999cited by this paper
• The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.

  1991cited by this paper
• The linear-quadratic formula and progress in fractionated radiotherapy.

  1989cited by this paper
• The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

  1985cited by this paper

• Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis

  2024cites this paper
• HIALURONO RŪGŠTIES INJEKCIJOS PANAUDOJIMAS SPINDULINĖS TERAPIJOS, TAIKOMOS PROSTATOS VĖŽIUI GYDYTI, KOMPLIKACIJŲ PREVENCIJAI

  2023cites this paper
• Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy

  2023cites this paper
• Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: a multi-institutional analysis of patients’ outcomes

  2021cites this paper
• Prostate cancer brachytherapy: SFRO guidelines 2021.

  2021cites this paper
• Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants

  2021cites this paper
• Filler Materials: Indications, Contraindications, and Special Considerations in Oncology Patients

  2020cites this paper
• Autologous fat as a rectal-prostate spacer for prostate brachytherapy: Results at 6 months.

  2019cites this paper
• Hyaluronate gel injection for rectum dose reduction in gynecologic high-dose-rate brachytherapy: initial Japanese experience

  2019cites this paper
• Salvage CyberKnife-Based Reirradiation of Patients With Recurrent Prostate Cancer: The Single-Center Experience

  2018cites this paper
• Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: repeated use of a polyethylene glycol hydrogel spacer

  2018cites this paper
• Reduction of rectal toxicity in prostate cancer radiation therapy by implantable rectum spacers

  2018cites this paper
• Magnetic resonance imaging-based salvage brachytherapy: Moving toward a focal paradigm.

  2017cites this paper
• Salvage Prostate Brachytherapy for Postradiation Local Failure

  2017cites this paper
• Focal Brachytherapy and Intensity-Modulated Radiation Therapy

  2017cites this paper
• Rectum and bladder spacing in cervical cancer brachytherapy using a novel injectable hydrogel compound.

  2017cites this paper